Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AGC Biologics Expands Development Capacities for pDNA Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

AGC Biologics Expands Development Capacities for pDNA Services

Expansion at Heidelberg site will help meet the growing demand for plasmid DNA offerings.

By: Contract Pharma

Contract Pharma Staff

AGC Biologics has unveiled the expansion of its pDNA Center of Excellence in Heidelberg, Germany. The global biopharmaceutical contract development and manufacturing organization (CDMO) is further expanding to meet the growing need for process development and manufacturing for plasmid DNA (pDNA).
 
“It is a priority to keep up with the growing demand for plasmid DNA offerings,” said Patricio Massera, chief executive officer, AGC Biologics.
 
The €1 million investment in a laboratory build-out includes a significant increase of lab area, additional staffing and state-of-the-art equipment, to foster high-throughput techniques and quality by design processes. This will further expand AGC Biologics’ service portfolio and build on a track record of more than seven years in commercial plasmid manufacturing.
 
Kasper Moller, chief technology officer, AGC Biologics, said, “This expansion will enable us to be even more efficient, as we meet our customers’ pDNA demand.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters